Following institutional review board approval and written informed consent , critically ill surgical patients more than or equal to @ years with suspected heparin-induced thrombocytopenia , were randomly assigned to receive double-blind argatroban or lepirudin anticoagulation targeting an activated Partial Thromboplastin Time ( aPTT ) of @ to @ times baseline .